ANTHONY LITTLE: Open Payments
NPI 1366784514 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,479 in 193 payments from 18 companies in 2025. Trend: 2023 $2,005 · 2024 $2,235 · 2025 $2,479
Food & beverage: $2,479
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 64 | $748 |
| Galderma Laboratories, L.P. | 31 | $219 |
| Novartis Pharmaceuticals Corporation | 15 | $200 |
| Arcutis Biotherapeutics, Inc. | 18 | $187 |
| ABBVIE INC. | 11 | $172 |
| MAYNE PHARMA COMMERCIAL LLC | 14 | $167 |
| Lilly USA, LLC | 8 | $141 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $137 |
| Amgen Inc. | 6 | $102 |
| Organon LLC | 5 | $92 |
Products named: TREMFYA, AXERT, Zoryve, NEMLUVIO, EBGLYSS, ILUMYA, SKYRIZI, OTEZLA.
Industry payments across PA — which companies pay providers there.
